AI assistant
Sending…
EyePoint Pharmaceuticals, Inc. — Director's Dealing 2017
Dec 19, 2017
32254_dirs_2017-12-19_36dc4a2a-b90b-482a-b961-8ef0b281f576.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: pSivida Corp. (PSDV)
CIK: 0001314102
Period of Report: 2017-12-15
Reporting Person: Peterson Kristine (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-12-15 | Employee Stock Option (right to buy) | $1.77 | A | 40000 | Acquired | 2027-06-27 | Common Stock (40000) | Direct |
Footnotes
F1: The option becomes exercisable in three equal annual installments beginning on June 27, 2018.
More from EyePoint Pharmaceuticals, Inc.
Regulatory Filings
2026
May 14
Regulatory Filings
2026
May 6
Regulatory Filings
2026
Apr 13
Director's Dealing
2026
Mar 24
Regulatory Filings
2026
Mar 20
Regulatory Filings
2026
Mar 4
Regulatory Filings
2026
Mar 2
Director's Dealing
2026
Feb 18
Major Shareholding Notification
2026
Feb 12
Director's Dealing
2026
Jan 7